|
2024
|
Invention
|
Methods of improving renal function. Provided herein are methods of improving kidney function in ... |
|
|
Invention
|
Methods of improving renal function.
Provided herein are methods of improving kidney function in... |
|
2023
|
Invention
|
Treatment of iga nephropathy using an endothelin receptor antagonist and an april binding antibod... |
|
|
Invention
|
Treatment of iga nephropathy using an endothelin receptor antagonist and an april binding antibody |
|
|
Invention
|
Substituted indole compounds and methods of use thereof. Provided herein are substituted indole c... |
|
|
Invention
|
Methods of reducing disease flares.
Provided herein are methods of reducing the incident of dise... |
|
|
Invention
|
Methods of treating focal segmental glomerulosclerosis with atrasentan.
Provided herein are meth... |
|
|
Invention
|
Methods of treating focal segmental glomerulosclerosis with atrasentan. Provided herein are metho... |
|
|
Invention
|
Methods of treating focal segmental glomerulosclerosis with atrasentan |
|
2022
|
Invention
|
Inhibiting mesangial cell activation.
Provided herein are methods of inhibiting mesangial cell a... |
|
|
Invention
|
Methods of treating kidney diseases.
Provided herein are methods of treating kidney diseases in ... |
|
2021
|
P/S
|
Medicines, drugs, therapeutic pharmaceuticals, pharmaceutical preparations, therapeutic agents fo... |
|
|
Invention
|
Methods of treating iga nephropathy with atrasentan.
Provided herein are methods of treating IgA... |
|
|
Invention
|
Methods of treating iga nephropathy with an april binding antibody.
Formulation and use of antib... |
|
|
Invention
|
Methods of treating iga nephropathy with an april binding antibody. Formulation and use of antibo... |
|
|
Invention
|
Methods of treating diabetic kidney disease.
Provided herein are methods of treating diabetic ki... |
|
|
Invention
|
Methods of treating diabetic kidney disease. Provided herein are methods of treating diabetic kid... |
|
2020
|
Invention
|
Methods of treating iga nephropathy with atrasentan. Provided herein are methods of treating IgA ... |
|
|
Invention
|
Methods and compositions for treatment of cancer and infectious diseases. The present invention r... |
|
|
P/S
|
Medicines, drugs, therapeutic pharmaceuticals, pharmaceutical preparations, biologics, biologic p... |
|
2019
|
Invention
|
Imidazopyridazinone compounds and uses thereof.
The present invention relates to imidazopyridazi... |
|
|
Invention
|
Dc-sign antibody conjugates comprising sting agonists.
Provided herein are immunoconjugates comp... |
|
|
Invention
|
Compositions and methods for activating “stimulator of interferon gene”13 dependent signalling. T... |
|
|
Invention
|
Triazine compounds and uses thereof.
The present invention relates to triazine compounds. The pr... |
|
|
Invention
|
Triazine compounds and uses thereof. The present invention relates to triazine compounds. The pre... |
|
|
Invention
|
Combination therapy for the treatment of cancer.
The present disclosure relates to a pharmaceuti... |
|
2018
|
Invention
|
Pyrazolopyrimidinone compounds and uses thereof. The present invention relates to pyrazolopyrimid... |
|
|
Invention
|
Bis 2′-5′-rr-(3′f-a)(3′f-a) cyclic dinucleotide compound and uses thereof. The present invention ... |
|
2017
|
Invention
|
Locked nucleic acid cyclic dinucleotide compounds and uses thereof. The present invention provide... |
|
|
Invention
|
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods ... |
|
2016
|
Invention
|
Compositions and methods for activating “stimulator of interferon gene”-dependent signalling. The... |
